The chief executive of America's oldest pro-life organization told Fox News Digital that President Donald Trump's FDA nominee, Dr. Heidi Overton, could bring renewed scrutiny to mifepristone, the abortion drug at the center of an ongoing federal safety review.John Mize, CEO of Americans United for Life (AUL), said he has had five or six conversations with Overton, who is known for her pro-life views. She currently serves as Trump's deputy assistant for domestic policy."I think she's going to bring objectivity to the issue of mifepristone in a way that will expose this drug for the damage it ca...
Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
HALO Newsroom
Aug 25, 2026 • 1 week ago
HALO Observer Insight
An independent HALO consumer takeaway — for costs, wellness, or policy context — will appear here automatically for this story. HALO adds this original editorial insight to every syndicated report before publication.